Premium Nahrungsergänzungsmittel | artgerecht

Short Cognitive Performance Test (SKT) – Dementia Screening

The Short Cognitive Performance Test (SKT) is a neuropsychological assessment tool used to evaluate memory and attention deficits, commonly applied in the diagnosis and monitoring of dementia.

Regular tips about health Regular tips about health

Things worth knowing about "Short Cognitive Performance Test"

The Short Cognitive Performance Test (SKT) is a neuropsychological assessment tool used to evaluate memory and attention deficits, commonly applied in the diagnosis and monitoring of dementia.

What is the Short Cognitive Performance Test?

The Short Cognitive Performance Test (German: Syndrom-Kurz-Test, abbreviated SKT) is a standardized neuropsychological test designed to assess cognitive performance, particularly in the domains of memory and attention. It is widely used for the early detection and ongoing monitoring of dementia, including Alzheimer disease. The test was originally developed by Erzigkeit in 1977 and has since been revised and standardized multiple times.

Structure and Administration

The SKT consists of nine subtests, each of which is time-limited. The total administration time is approximately 10 to 15 minutes, making it highly practical for routine clinical use. The subtests assess a range of cognitive functions through tasks involving symbols, numbers, and objects.

Naming of objects and symbols
Reading of numbers and symbols
Arranging objects according to a given pattern
Short-term and long-term memory (recognition and free recall)
Concentration and sustained attention

Each subtest is timed, and both the time taken and the number of errors contribute to the overall score. The resulting SKT total score provides an estimate of the individual cognitive performance level.

Areas of Application

The SKT is primarily used in the following clinical and research contexts:

Early detection of dementia and mild cognitive impairment (MCI)
Monitoring disease progression in patients already diagnosed with dementia
Evaluation of treatment effects in clinical trials of anti-dementia medications
Neuropsychological baseline assessments in memory clinics and geriatric care settings

Scoring and Interpretation

The SKT is scored using age- and education-adjusted normative tables. The total score is assigned to one of five severity categories:

Category 0: No impairment – within normal range
Category 1: Mild impairment – borderline result
Category 2: Moderate impairment – indicative of early cognitive decline
Category 3: Moderately severe impairment
Category 4: Severe impairment – significant cognitive deficits

An elevated SKT score indicates cognitive deficits and should always be interpreted in the broader clinical context. The SKT does not replace a full neuropsychological evaluation but provides valuable information for further diagnostic workup.

Advantages and Limitations

Advantages

Brief administration time (approximately 10–15 minutes)
Low burden on the patient and easy to administer
Well-validated and widely used in clinical research
Sensitive to changes over the course of illness
Available in several parallel versions, reducing practice effects in repeated assessments

Limitations

Cannot be used as a standalone diagnostic tool for dementia
Results may be influenced by educational background, language proficiency, and test conditions
Limited validity in patients with severe cognitive impairment

Comparison with Other Tests

The SKT is often used alongside other cognitive screening tools such as the Mini-Mental State Examination (MMSE) or the Montreal Cognitive Assessment (MoCA). While the MMSE covers a broader range of cognitive domains, the SKT places a stronger emphasis on time-based performance measurement and is particularly suitable for longitudinal monitoring of cognitive change.

References

Erzigkeit, H. (1977). SKT – Ein Kurztest zur Erfassung von Gedächtnis- und Aufmerksamkeitsstörungen. Geromed GmbH, Erlangen. Updated versions available.
Lehfeld, H. & Erzigkeit, H. (1997). The SKT – a short cognitive performance test for assessing deficits of memory and attention. International Psychogeriatrics, 9(S1), 115–121.
World Health Organization (WHO). (2021). Global Status Report on the Public Health Response to Dementia. Geneva: WHO Press.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.